Skip to main content
letter
. 2022 Jun 30:10.1111/jdv.18337. Online ahead of print. doi: 10.1111/jdv.18337

Figure 1.

Figure 1

Changes in the proportion (%) of newly diagnosed (a) and treated in inpatient setting (b) malignant melanomas by quarters of 2020 and 2021 compared to 2019 (assumed as 100%). The fluctuations go in line with the rising SARS‐CoV‐2 infection numbers in Germany (March and October 2020 as well as April and September 2021 8 ).